Global CRO body finds fault with India's online drug trial tracking plans
This article was originally published in SRA
Executive Summary
A proposal by the Indian drug regulatory authority to establish an online system for approving and monitoring information from drug clinical trials is viewed as problematic by ACRO, the US-based global association of clinical research organizations, as problematic. The proposal, says ACRO, raises "a number of questions and concerns"1,2.